Tetsuo Asaki

783 total citations
14 papers, 658 citations indexed

About

Tetsuo Asaki is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Tetsuo Asaki has authored 14 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Tetsuo Asaki's work include Eosinophilic Disorders and Syndromes (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Tetsuo Asaki is often cited by papers focused on Eosinophilic Disorders and Syndromes (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Tetsuo Asaki collaborates with scholars based in Japan and Switzerland. Tetsuo Asaki's co-authors include Taisuke Hamamoto, Keiichi Kuwano, Kenji Kuwabara, Tomoko Niwa, Tetsuhiro Yamada, Shinya Kimura, Haruna Naito, Yukiteru Sugiyama, Asami Hashino and Tatsushi Wakayama and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tetsuo Asaki

14 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuo Asaki Japan 11 245 189 163 162 136 14 658
Michael W. Lago United States 10 161 0.7× 115 0.6× 209 1.3× 27 0.2× 91 0.7× 13 538
Hans-Peter Gschwind Switzerland 10 148 0.6× 105 0.6× 181 1.1× 52 0.3× 36 0.3× 15 466
Hassan Elokdah United States 13 215 0.9× 68 0.4× 185 1.1× 58 0.4× 118 0.9× 18 665
Barbara J. Haertlein United States 14 176 0.7× 110 0.6× 270 1.7× 31 0.2× 271 2.0× 24 734
Maria Valentine United States 11 81 0.3× 25 0.1× 201 1.2× 93 0.6× 53 0.4× 13 694
Shin‐Shay Tian United States 14 440 1.8× 121 0.6× 200 1.2× 55 0.3× 74 0.5× 18 740
Lori Capone Switzerland 9 307 1.3× 73 0.4× 466 2.9× 30 0.2× 68 0.5× 13 1.0k
Dean J. Welsch United States 13 117 0.5× 38 0.2× 313 1.9× 38 0.2× 44 0.3× 22 686
Kōjirō Yasunaga Japan 14 335 1.4× 41 0.2× 106 0.7× 97 0.6× 12 0.1× 51 606
Lorraine Leblond Canada 14 237 1.0× 143 0.8× 243 1.5× 16 0.1× 321 2.4× 21 835

Countries citing papers authored by Tetsuo Asaki

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Asaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Asaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Asaki more than expected).

Fields of papers citing papers by Tetsuo Asaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Asaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Asaki. The network helps show where Tetsuo Asaki may publish in the future.

Co-authorship network of co-authors of Tetsuo Asaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Asaki. A scholar is included among the top collaborators of Tetsuo Asaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Asaki. Tetsuo Asaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Asaki, Tetsuo, Keiichi Kuwano, Keith Morrison, et al.. (2015). Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension. Journal of Medicinal Chemistry. 58(18). 7128–7137. 69 indexed citations
2.
Asaki, Tetsuo, et al.. (2008). Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor α (PPARα) agonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 2128–2132. 9 indexed citations
3.
Asaki, Tetsuo, Taisuke Hamamoto, Yukiteru Sugiyama, Keiichi Kuwano, & Kenji Kuwabara. (2007). Structure–activity studies on diphenylpyrazine derivatives: A novel class of prostacyclin receptor agonists. Bioorganic & Medicinal Chemistry. 15(21). 6692–6704. 45 indexed citations
4.
5.
Nakamura, Akio, Tetsuhiro Yamada, & Tetsuo Asaki. (2007). Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonist. Bioorganic & Medicinal Chemistry. 15(24). 7720–7725. 28 indexed citations
6.
Hamasaki, Tomohiro, Toshihiko Inoue, Tatsushi Wakayama, et al.. (2007). Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives. Bioorganic & Medicinal Chemistry Letters. 17(10). 2712–2717. 26 indexed citations
7.
Asaki, Tetsuo, Taisuke Hamamoto, Yukiteru Sugiyama, et al.. (2007). Structure–activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(23). 6588–6592. 5 indexed citations
8.
Kuwano, Keiichi, Asami Hashino, Tetsuo Asaki, et al.. (2007). 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), an Orally Available and Long-Acting Prostacyclin Receptor Agonist Prodrug. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1181–1188. 141 indexed citations
9.
Niwa, Tomoko, Tetsuo Asaki, & Shinya Kimura. (2007). NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor.. PubMed. 2. 93–106. 17 indexed citations
10.
Niwa, Tomoko, Tetsuo Asaki, & Shinya Kimura. (2007). NS-187 (INNO-406), a Bcr-Abl/Lyn Dual Tyrosine Kinase Inhibitor. 2. 1072214952–1072214952. 19 indexed citations
11.
Asaki, Tetsuo, et al.. (2005). Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(5). 1421–1425. 45 indexed citations
12.
Kimura, Shinya, Haruna Naito, Hidekazu Segawa, et al.. (2005). NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia. Blood. 106(12). 3948–3954. 198 indexed citations
13.
Kimura, Shinya, Haruna Naito, Asumi Yokota, et al.. (2005). A Dual Bcr-Abl/Lyn Tyrosine Kinase Inhibitor, NS-187, Is a Novel Agent for Imatinib-Resistant Leukemia.. Blood. 106(11). 1522–1522. 2 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael W. Lago Breakdown of academic impact, for papers by Hans-Peter Gschwind Breakdown of academic impact, for papers by Hassan Elokdah Breakdown of academic impact, for papers by Barbara J. Haertlein Breakdown of academic impact, for papers by Maria Valentine Breakdown of academic impact, for papers by Shin‐Shay Tian Breakdown of academic impact, for papers by Lori Capone Breakdown of academic impact, for papers by Dean J. Welsch Breakdown of academic impact, for papers by Kōjirō Yasunaga Breakdown of academic impact, for papers by Lorraine Leblond
Rankless by CCL
2026